HeadInvest LLC’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-411
Closed -$17.4K 321
2023
Q3
$17.4K Buy
+411
New +$17.4K ﹤0.01% 484